Supported by National Research Foundation



Synthetic biology is a maturing scientific discipline that combines science and engineering in order to design and build new biological parts, devices and systems. Synthetic biology offers enormous opportunities to benefit society with promising applications in areas such as energy, healthcare and the environment. Launched in September 2016, the Singapore Consortium for Synthetic Biology, SINERGY aims to consolidate Singapore’s capabilities in synthetic biology and harness synergies across industry sectors to create a vibrant and globally connected bio-based economy in Singapore. Efforts to foster interactions and co-development between the industry, universities and research institutes will encourage user-inspired research, augment manpower development, as well as speed up the translation of expertise in synthetic biology for industry applications. SINERGY is supported by the National Research Foundation and hosted at the National University of Singapore.


  • Upgrade industry technological abilities through active engagement and co-development among industry, universities and research institutes
  • Harness synergies across R&D collaborative projects
  • Facilitate manpower deployment from institutes of higher learning to industries
  • Provide a one-stop, go-to national resource centre for companies and members

Key areas of interest

  • Advanced Manufacturing for Specialty Chemicals
  • Protein and Enzyme Engineering
  • Biosensors and Cell-Free Systems
  • Biomimetics
  • Synthetic Genomics
  • Proprietary Strain Construction and Optimization


NUS Synthetic Biology Foundry

NUS Synthetic Biology Foundry represents a hallmark of synthetic biology research in driving foundational science towards translational clinical and industrial biotechnology applications. Equipped with state-of-the-art robotic system that is interfaced with various high throughput analytical instruments, the Foundry enables systematic (re)designing, building, testing and learning of synthetic biological systems on a highly efficient, automated manufacturing platform. By fostering advanced research through international collaborations, the Foundry aims to become a central hub for cutting-edge synthetic biology research in Asia.


Gas Chromatography
Mass Spectrometer

Ultra-High Performance Liquid
Chromatography System

Quadrupole Time-of-Flight
Liquid Chromatography/
Mass Spectrometry System

Fluorescence Activated
Cell Sorter


Real-Time Polymerase
Chain Reaction
(PCR) System



For information on facility usage,

please contact us.


Industry Members

Academic Members


The Consortium membership is open to companies that:

  • Are actively involved in synthetic biology-related manufacturing, design or R&D
  • Apply synthetic biology approaches in their product or manufacturing processes
  • Provide technologies, products or services that support synthetic biology applications
                                                                            Non Start-Up Company Start-up Company
Membership Entrance Fee S$10,000 S$1,000 (e)
Annual Membership Fees S$1,000 S$1,000 (e)


(a) The Membership Fee is inclusive of Goods and Services Tax.

(b) The Membership Fee shall be payable in advance of the applicable membership year within thirty (30) days from the date of invoice issued by NUS.

(c) The effective date of membership is 1st January, 1st May, or 1st September of year of application, as determined in accordance with Sections 3 and 4 of the Membership Application Form, and membership is effective for a whole calendar year.

(d) Membership is renewable on an annual basis, in advance, and shall be effective from 1st January, 1st May, or 1st September of the following year, according to the date of membership registration.

(e) Start-ups which are in their first 5 years of incorporation and with revenue under S$ 1 million, can qualify for waiver of the Membership Fee.

For information on membership fees,

please contact us.


Dr Andrea Pavesi

Shaping in vitro solid tumor microenvironments models for T cell therapy and drug discovery

Dr Andrea Pavesi

Shaping in vitro solid tumor microenvironments models for T cell therapy and drug discovery

GBA Webinar Series

GBA Webinar Series 1

Robert C. Robinson
Trevor C. Charles
Slaven Garaj

Nanopore analysis of biological molecules and complexes

Yi-Chin Toh
David A. Weitz
Brian SH Koh

“Me? An Entrepreneur?”

Benjamin C.K. Tee

Bio-inspired Electronic Skins

Cha Hyung Joon
Daniel Yap
Cao Bin
Richard Kelwick

Topic 2: Patent Infringement and Patent Search

Kevin T. Geiss

Airman Systems Directorate

Li Xiaodan

Visualizing Membrane Proteins Using X-ray and Electron

Steven C. Almo
John A. Gerlt

Tools and Strategies for Discovering Novel Enzymes in Novel Metabolic Pathways

Madhu Rao

Southeast Asia in the Anthropocene: Can synthetic biology address conservation challenges?

Chris Voigt

Computation in Living Cells

Chase Beisel

The CRISPR revolution

Victor de Lorenzo

DOE-ICL-NUS Foundry Technical Meeting

Mayasari Lim


Hal Alper

Engineering an Expanded Chemical Palette in Cells

The Seventh International Meeting on Synthetic Biology | SB7.0


SINERGY Seed Grant

Contact Us